Citation Impact
Citing Papers
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
2017
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation
2015
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Escitalopram
2005
No health without mental health
2007 Standout
CYTOCHROME P450 3A-MEDIATED METABOLISM OF BUSPIRONE IN HUMAN LIVER MICROSOMES
2005
Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract
2011
Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions
2024 StandoutNobel
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine
2003
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis
2016
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Hydrophobic mismatch drives self-organization of designer proteins into synthetic membranes
2024 StandoutNobel
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
Negative regulation of NF‐κB action by Set9‐mediated lysine methylation of the RelA subunit
2009
Engineering primary T cells with chimeric antigen receptors for rewired responses to soluble ligands
2020
Genetic engineering of T cells for immunotherapy
2021
The Principles of Engineering Immune Cells to Treat Cancer
2017
Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors
2015
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Hepatocellular carcinoma
2021 Standout
CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
2004
Genetically engineered T cells for cancer immunotherapy
2019
DNA methylation: roles in mammalian development
2013 Standout
RVB1/RVB2: Running Rings around Molecular Biology
2009
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
2018
Delivery technologies for cancer immunotherapy
2019 Standout
Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs
2005
Escitalopram in the Treatment of Depressed Elderly Patients
2005
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Use of Psychotropic Medications Among HIV-Infected Patients in the United States
2003
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
2008
Next-generation regulatory T cell therapy
2019
Epigenetic phenomena linked to diabetic complications
2010
Comparison of Duloxetine, Escitalopram, and Sertraline Effects on Cytochrome P450 2D6 Function in Healthy Volunteers
2007
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Intrinsically disordered proteins in cellular signalling and regulation
2014 Standout
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants
2002
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Posttranslational Modification of p53: Cooperative Integrators of Function
2009
Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
2010 StandoutNobel
Crosstalk in NF-κB signaling pathways
2011 Standout
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
2016
Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram
2002
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
2019
Epigenetic modifications and human disease
2010 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro
2010
Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML
2017
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma
2002
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants
2002
Lysine Acetylation: Codified Crosstalk with Other Posttranslational Modifications
2008
Therapeutic T cell engineering
2017 Nature
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Antibacterial drug discovery in the resistance era
2016 StandoutNature
IFITM3 directly engages and shuttles incoming virus particles to lysosomes
2018 StandoutNobel
Linking DNA methylation and histone modification: patterns and paradigms
2009 Standout
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3
2006 StandoutNobel
Taking regulatory T cells into medicine
2021 StandoutNobel
Use of Robust Classification Techniques for the Prediction of Human Cytochrome P450 2D6 Inhibition
2003
Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells
2009
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Escitalopram in the Treatment of Depressed Elderly Patients
2005
Transport, metabolism and elimination mechanisms of anti-HIV agents
1999
Competitive Inhibition of the Enzyme-Mimic Activity of Gd-Based Nanorods toward Highly Specific Colorimetric Sensing of l -Cysteine
2017
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
2019
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Enzyme Promiscuity: A Mechanistic and Evolutionary Perspective
2010 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier
2012 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
A Quantitative Index of Substrate Promiscuity
2007
Liposomal daunorubicin as treatment for Kaposi's sarcoma.
2007
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
Precise T cell recognition programs designed by transcriptionally linking multiple receptors
2020 Science
Size-dependent activation of CAR-T cells
2022
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
2017
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Challenges of Antibacterial Discovery
2011
Regulation of the Trafficking and Antiviral Activity of IFITM3 by Post-Translational Modifications
2014
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of Brian Granda being referenced
Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
2015
Appetite Suppressant Drugs as Inhibitors of Human Cytochromes P450
1998
Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects
1999
Methylation of p53 by Set7/9 Mediates p53 Acetylation and Activity In Vivo
2008
Inhibition of Human Cytochrome P450 Isoforms by Nonnucleoside Reverse Transcriptase Inhibitors
2001
Microsomal Protein Concentration Modifies the Apparent Inhibitory Potency of CYP3A Inhibitors
2002
Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with Ritonavir
1998
Gepirone and 1-(2-pyrimidinyl)-piperazine in vitro: human cytochromes mediating transformation and cytochrome inhibitory effects
1998
Zolpidem metabolism in vitro: responsible cytochromes, chemical inhibitors, and in vivo correlations
1999
Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.
2001
Biophysical Investigation of the Mode of Inhibition of Tetramic Acids, the Allosteric Inhibitors of Undecaprenyl Pyrophosphate Synthase
2010
Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In-vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A
1998